[Human C-peptide. Part III: dynamics of secretion of beta-cells in adult diabetics following glibenclamide-glucose i.v. (human C-peptide III) (author's transl)].
D000328:Adult; D000368:Aged; D002096:C-Peptide / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D005905:Glyburide / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000378:metabolism*; D013607:Tablets
D002096:C-Peptide; D007328:Insulin; D010455:Peptides; D013607:Tablets; D005947:Glucose; D005905:Glyburide
Humanes C-Peptid. Teil III:Sekretionsdynamik der Beta-Zellen erwachsener Diabetiker nach Glibenclamid-Glukose i.v. (Humanes C-Peptid, III).